SCOPUS 정보 검색 플랫폼

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 3, 2002, Pages 746-754

Pharmacokinetic modeling and simulations of interaction of amprenavir and ritonavir

(3) Sale, Mark a Sadler, Brian M a Stein, Daniel S a

a GLAXOSMITHKLINE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPRENAVIR; RITONAVIR;

ABSORPTION; ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; COMPUTER MODEL; COMPUTER SIMULATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IC 50; MALE; MONTE CARLO METHOD; NONHUMAN; NORMAL HUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN BINDING; RANDOMIZED CONTROLLED TRIAL; VIRUS ISOLATION;

ADOLESCENT; ADULT; ALGORITHMS; ANTI-HIV AGENTS; CARBAMATES; COMPUTER SIMULATION; DRUG INTERACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MONTE CARLO METHOD; REPRODUCIBILITY OF RESULTS; RITONAVIR; SULFONAMIDES;

EID: 0036173443 PISSN: 00664804 EISSN: None Source Type: Journal
DOI: 10.1128/AAC.46.3.746-754.2002 Document Type: Article

Times cited : (49)

References (30)

1
- 0033001617
- Indinavir concentrations and antiviral effect
- (1999) Pharmacotherapy , vol.19 , pp. 708-712
- Acosta, E.¹ Henry, K.² Baken, L.³ Page, L.⁴ Fletcher, C.⁵

2
- 0034685037
- Antiretroviral therapy in adults. Updated recommendations of the International AIDS Society - USA Panel
- (2000) JAMA , vol.283 , pp. 381-390
- Carpenter, C.¹ Cooper, D.² Fischl, M.³ Gatell, J.⁴ Gazzard, B.⁵ Hammer, S.⁶ Hirsch, M.⁷ Jacobsen, D.⁸ Katzenstein, D.⁹ Montaner, J.¹⁰ Richman, D.¹¹ Saag, M.¹² Schechter, M.¹³ Schooley, R.¹⁴ Thompson, M.¹⁵ Vella, S.¹⁶ Yeni, P.¹⁷ Volberding, P.¹⁸

3
- 0033827608
- Drug resistance and predicted virologic responses to human immunodeficiency virus type I protease inhibitor therapy
- (2000) J. Infect. Dis. , vol.182 , pp. 758-765
- Condra, J.H.¹ Petropoulos, C.J.² Ziermann, R.³ Schleif, W.A.⁴ Shivaprakash, M.⁵ Emini, E.A.⁶

4
- 0028846165
- A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease
- (1995) N. Engl. J. Med. , vol.333 , pp. 1528-1533
- Danner, S.¹ Carr, A.² Leonard, J.³ Lehman, L.⁴ Gudiol, F.⁵ Gonzales, J.⁶ Raventos, A.⁷ Rubio, R.⁸ Bouza, E.⁹ Pintado, V.¹⁰ Gil Aguado, A.¹¹ De Lomas, J.¹² Delgado, R.¹³ Borleffs, J.¹⁴ Hsu, A.¹⁵ Valdes, J.¹⁶ Boucher, C.¹⁷ Cooper, D.¹⁸

5
- 0031024623
- HIV-1 protease inhibitors. A review for clinicians
- (1997) JAMA , vol.277 , pp. 145-153
- Deeks, S.¹ Smith, M.² Holodniy, M.³ Kahn, J.⁴

6
- 0030852009
- Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir, and indinavir
- (1997) Br. J. Clin. Pharm. , vol.44 , pp. 190-194
- Eagling, V.¹ Back, D.² Barry, M.³

7
- 0032845172
- Pharmacologic considerations for therapeutic success with antiviral agents
- (1999) Ann. Pharmacother. , vol.33 , pp. 989-995
- Fletcher, C.¹

8
- 0034065983
- Pharmacologic characteristics of indinavir, didanosine, and stavudine in human immunodeficiency virus-infected children receiving combination therapy
- (2000) Antimicrob. Agents Chemother. , vol.44 , pp. 1029-1034
- Fletcher, C.¹ Brundage, R.² Remmel, R.³ Page, L.⁴ Weller, D.⁵ Calles, N.⁶ Simon, C.⁷ Kline, M.⁸

9
- 0030869269
- Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy
- (1997) N. Engl. J. Med. , vol.337 , pp. 734-739
- Gulick, R.¹ Mellors, J.² Havlir, D.³ Eron, J.⁴ Gonzalez, C.⁵ McMahon, D.⁶ Richman, D.⁷ Valentine, F.⁸ Jonas, L.⁹ Meibohm, A.¹⁰ Emini, E.¹¹ Chodakewitz, J.¹² Deutsch, P.¹³ Holder, D.¹⁴ Schleif, W.¹⁵ Condra, J.¹⁶

10
- 0442268112
- A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less
- (1997) N. Engl. J. Med. , vol.337 , pp. 725-733
- Hammer, S.¹ Squires, K.² Hughes, M.³ Grimes, J.⁴ Demeter, L.⁵ Currier, J.⁶ Eron, J.⁷ Feinberg, J.⁸ Balfour, H.⁹ Deyton, L.¹⁰ Chodakewitz, J.¹¹ Cook, J.¹²

11
- 0344474694
- A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugs
- (1998) Antimicrob. Agents Chemother. , vol.42 , pp. 269-276
- Hertogs, K.¹ De Bethune, M.² Miller, V.³ Ivens, T.⁴ Schel, P.⁵ Van Cauwenberge, A.⁶ Van Den Eynde, C.⁷ Van Gerwen, V.⁸ Azijn, H.⁹ Van Houtte, M.¹⁰ Peeters, F.¹¹ Staszewski, S.¹² Conant, M.¹³ Bloor, S.¹⁴ Kemp, S.¹⁵ Larder, B.¹⁶ Pauwels, R.¹⁷

12
- 7144257182
- Pharmacokinetic interactions between two human immunodeficiency virus protease inhibitors, ritonavir and saquinavir
- (1998) Clin. Pharmacol. Ther. , vol.63 , pp. 453-464
- Hsu, A.¹ Granneman, G.² Cao, G.³ Carothers, L.⁴ El-Shourbagy, T.⁵ Baroldi, P.⁶ Erdman, K.⁷ Brown, F.⁸ Sun, E.⁹ Leonard, J.¹⁰

13
- 0031785117
- Pharmacokinetic interaction between ritonavir and indinavir in healthy volunteers
- (1998) Antimicrob. Agents Chemother. , vol.42 , pp. 2784-2791
- Hsu, A.¹ Granneman, G.² Cao, G.³ Carothers, L.⁴ Japour, A.⁵ El-Shourbagy, T.⁶ Dennis, S.⁷ Berg, J.⁸ Erdman, K.⁹ Leonard, J.¹⁰ Sun, E.¹¹

14
- 0031790709
- Metabolism of the human immunodeficiency virus protease inhibitors indinavir and ritonavir by human intestinal microsomes and expressed cytochrome P4503A/3A5: Mechanism-based inactivation of cytochrome P4503A by ritonavir
- (1998) Drug Metab. Dispos. , vol.26 , pp. 552-561
- Koudriakova, T.¹ Iatsimirskaia, E.² Utkin, I.³ Gangl, E.⁴ Vouros, P.⁵ Storozhuk, E.⁶ Orza, D.⁷ Marinina, J.⁸ Gerber, N.⁹

15
- 0032811807
- Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: A positive drug-drug interaction
- (1999) Drug Metab. Dispos. , vol.27 , pp. 902-908
- Kumar, G.¹ Dykstra, J.² Roberts, E.³ Jayanti, V.⁴ Hickman, D.⁵ Uchic, J.⁶ Yao, Y.⁷ Surber, B.⁸ Thomas, S.⁹ Granneman, G.¹⁰

16
- 0030430035
- Cytochrome P450-mediated metabolism of the HIV-1 protease inhibitor ritonavir (ABT-538) in human liver microsomes
- (1996) J. Pharmacol. Exp. Ther. , vol.277 , pp. 423-431
- Kumar, G.¹ Rodrigues, D.² Buko, A.³ Denissen, J.⁴

17
- 0033550965
- Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: A prospective cohort study
- (1999) Lancet , vol.353 , pp. 863-868
- Ledergerber, B.¹ Egger, M.² Opravil, M.³ Telenti, A.⁴ Hirschel, B.⁵ Battegay, M.⁶ Vernazza, P.⁷ Sudre, P.⁸ Flepp, M.⁹ Furrer, H.¹⁰ Francioli, P.¹¹ Weber, R.¹²

18
- 0030792728
- Toxicity, efficacy, plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir and saquinavir
- (1997) AIDS , vol.11
- Lorenzi, P.¹ Yerly, S.² Abderrakim, K.³ Fathi, M.⁴ Rutschmann, O.⁵ Overbeck, J.V.⁶ Leduc, D.⁷ Perrin, L.⁸ Hirschel, B.⁹

19
- 0031054507
- Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patients
- (1997) AIDS , vol.11
- Merry, C.¹ Barry, M.G.² Mulcahy, F.³ Ryan, M.⁴ Heavey, J.⁵ Tjia, J.F.⁶ Gibbons, S.E.⁷ Breckenridge, A.M.⁸ Back, D.J.⁹

20
- 15444377672
- Ordered accumulation of mutations in HIV protease confers resistance to ritonavir
- (1996) Nat. Med. , vol.2 , pp. 760-766
- Molla, A.¹ Korneyeva, M.² Gao, Q.³ Vasavanonda, S.⁴ Schipper, P.⁵ Mo, H.⁶ Markowitz, M.⁷ Chernyavskiy, T.⁸ Niu, P.⁹ Lyons, N.¹⁰ Hsu, A.¹¹ Granneman, G.¹² Ho, D.¹³ Boucher, C.¹⁴ Leonard, J.¹⁵ Norbeck, D.¹⁶ Kempf, D.¹⁷

21
- 2642709177
- Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
- (1998) N. Engl. J. Med. , vol.338 , pp. 853-860
- Palella, F.¹ Delaney, K.² Moorman, A.³ Loveless, M.⁴ Fuhrer, J.⁵ Satten, G.⁶ Aschman, D.⁷ Holmberg, S.⁸

22
- 0032894127
- Human immunodeficiency virus protease inhibitors
- (1999) Pharmacotherapy , vol.19 , pp. 35-59
- Rana, K.¹ Dudley, M.²

23
- 0034801355
- Pharmacokinetic profile and tolerability of indinavirritonavir combinations in healthy volunteers
- (2001) Antimicrob. Agents Chemother. , vol.45 , pp. 2710-2715
- Saah, A.J.¹ Winchell, G.A.² Nessly, M.L.³ Seniuk, M.A.⁴ Rhodes, R.R.⁵ Deutsch, P.J.⁶

24
- 0035115820
- 1-acid glycoprotein on pharmacokinetics of amprenavir, a human immunodeficiency virus protease inhibitor
- (2001) Antimicrob. Agents Chemother. , vol.45 , pp. 852-856
- Sadler, B.¹ Gillotin, G.² Lou, Y.³ Stein, D.⁴

25
- 0006179308
- Pharmacokinetics and safety of amprenavir and ritonavir following multipledose, co-administration to healthy volunteers
- (2001) AIDS , vol.15 , pp. 1009-1018
- Sadler, B.¹ Piliero, J.² Preston, S.³ Lloyd, P.⁴ Lou, Y.⁵ Stein, D.⁶

26
- 0030317870
- + T-cell counts in HIV infected patients
- (1996) Ann. Intern. Med. , vol.124 , pp. 1039-1050
- Schapiro, J.¹ Winters, M.² Stewart, F.³ Efron, B.⁴ Norris, J.⁵ Kozal, M.⁶ Merigan, T.⁷

27
- 0019289897
- Evaluation of methods for estimating population pharmacokinetic parameters. I. Michaelis-Menten model-routine clinical pharmacokinetic data
- (1980) J. Pharmacokinet. Biopharm. , vol.8 , pp. 553-571
- Sheiner, L.¹ Beal, S.²

28
- 0029872589
- A 24-week open-label phase I/II evaluation of the HIV protease inhibitor MK-639 (indinavir)
- (1996) AIDS , vol.10 , pp. 485-492
- Stein, D.S.¹ Fish, D.² Bilello, J.³ Preston, S.⁴ Martineau, G.⁵ Drusano, G.⁶

29
- 0032168998
- Compliance issues in the treatment of HIV infection
- (1998) Am. J. Health-Syst. Pharm. , vol.55 , pp. 1817-1824
- Tseng, A.-I.¹

30
- 0032710406
- The steady-state plasma pharmacokinetics of indinavir alone and in combination with a low dose of ritonavir in twice daily dosing regimens in HIV-1-infected individuals
- (1999) AIDS , vol.13
- Van Heeswijk, R.P.¹ Veldkamp, A.I.² Hoetelmans, R.M.³ Mulder, J.W.⁴ Schreij, G.⁵ Hsu, A.⁶ Lange, J.M.⁷ Beijnen, J.H.⁸ Meenhorst, P.L.⁹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.